Astrana Health (NASDAQ:ASTH) Trading Down 6.3% – Should You Sell?

Astrana Health, Inc. (NASDAQ:ASTH)’s share price traded down 6.3% during trading on Tuesday . The stock traded as low as $27.42 and last traded at $27.3750. 100,146 shares were traded during mid-day trading, a decline of 78% from the average session volume of 457,647 shares. The stock had previously closed at $29.21.

Wall Street Analyst Weigh In

ASTH has been the topic of a number of research reports. Needham & Company LLC initiated coverage on Astrana Health in a research report on Friday, December 12th. They set a “buy” rating and a $28.00 price objective on the stock. Weiss Ratings reissued a “sell (d+)” rating on shares of Astrana Health in a report on Monday, December 29th. Jefferies Financial Group reaffirmed a “buy” rating on shares of Astrana Health in a report on Tuesday, November 25th. Barclays decreased their target price on shares of Astrana Health from $36.00 to $26.00 and set an “equal weight” rating on the stock in a research report on Monday, November 24th. Finally, TD Cowen dropped their price target on shares of Astrana Health from $40.00 to $35.00 and set a “buy” rating for the company in a research report on Monday, November 10th. Eight research analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $41.33.

Astrana Health Price Performance

The stock has a fifty day moving average of $24.36 and a 200-day moving average of $26.82. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.27. The firm has a market capitalization of $1.53 billion, a P/E ratio of 143.17, a PEG ratio of 0.71 and a beta of 0.87.

Astrana Health (NASDAQ:ASTH) last announced its earnings results on Thursday, November 6th. The company reported $0.01 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.46). The company had revenue of $956.05 million for the quarter, compared to analyst estimates of $952.83 million. Astrana Health had a return on equity of 1.26% and a net margin of 0.33%.Astrana Health’s revenue for the quarter was up 99.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.33 earnings per share. Equities analysts predict that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

Hedge Funds Weigh In On Astrana Health

Hedge funds and other institutional investors have recently bought and sold shares of the business. Amalgamated Bank grew its position in shares of Astrana Health by 3.4% during the 3rd quarter. Amalgamated Bank now owns 12,325 shares of the company’s stock worth $349,000 after buying an additional 409 shares during the period. Thrivent Financial for Lutherans lifted its position in shares of Astrana Health by 1.5% during the 3rd quarter. Thrivent Financial for Lutherans now owns 30,977 shares of the company’s stock valued at $878,000 after acquiring an additional 455 shares during the period. Principal Financial Group Inc. grew its holdings in shares of Astrana Health by 0.3% during the 3rd quarter. Principal Financial Group Inc. now owns 222,985 shares of the company’s stock worth $6,322,000 after purchasing an additional 611 shares in the last quarter. Savant Capital LLC increased its position in shares of Astrana Health by 2.2% in the third quarter. Savant Capital LLC now owns 30,713 shares of the company’s stock worth $871,000 after purchasing an additional 649 shares during the period. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in Astrana Health by 7.1% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 10,657 shares of the company’s stock valued at $265,000 after purchasing an additional 710 shares in the last quarter. 52.77% of the stock is owned by institutional investors.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.